Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial

Jonathan Rabinowitz; Stefan Badescu; Pavel Palamarchuk; Viktor Filyk; Anatolii Voloshchuk; Vadym Rud; Ellina Melnyk; Andrii Skrypnikov; Michael Davidson; Jay Saoud; Remy Luthringer

doi:10.1016/j.schres.2019.07.029

Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial

Jonathan Rabinowitz
, Stefan Badescu
, Pavel Palamarchuk
, Viktor Filyk
, Anatolii Voloshchuk
, Vadym Rud
, Ellina Melnyk
, Andrii Skrypnikov
, Michael Davidson
, Jay Saoud
, Remy Luthringer

The Louis & Gabi Weisfeld School of Social Work

Neuropsychiatric Hospital Craiova
Kherson Regional Psychiatric Hospital
Kharkiv Railway Clinical Hospital #1
Odesa Regional Medical Centre of Mental Health
Poltava Regional Clinical Psychiatry Hospital
Ukrainian Medical Stomatological Academy
Minerva Neurosciences

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Original language	English
Pages (from-to)	103-104
Number of pages	2
Journal	Schizophrenia Research
Volume	211
DOIs	https://doi.org/10.1016/j.schres.2019.07.029
State	Published - Sep 2019

Bibliographical note

Funding Information:
The study phase 2b clinical trial was funded by Minerva Neurosciences.

Funding

The study phase 2b clinical trial was funded by Minerva Neurosciences.

Funders
Minerva Neurosciences

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.schres.2019.07.029

Cite this

Rabinowitz, J., Badescu, S., Palamarchuk, P., Filyk, V., Voloshchuk, A., Rud, V., Melnyk, E., Skrypnikov, A., Davidson, M., Saoud, J., & Luthringer, R. (2019). Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial. Schizophrenia Research, 211, 103-104. https://doi.org/10.1016/j.schres.2019.07.029

@article{fa57a64079024677b6c78b32351ad959,

title = "Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial",

author = "Jonathan Rabinowitz and Stefan Badescu and Pavel Palamarchuk and Viktor Filyk and Anatolii Voloshchuk and Vadym Rud and Ellina Melnyk and Andrii Skrypnikov and Michael Davidson and Jay Saoud and Remy Luthringer",

note = "Funding Information: The study phase 2b clinical trial was funded by Minerva Neurosciences. ",

year = "2019",

month = sep,

doi = "10.1016/j.schres.2019.07.029",

language = "אנגלית",

volume = "211",

pages = "103--104",

journal = "Schizophrenia Research",

issn = "0920-9964",

publisher = "Elsevier B.V.",

}

Rabinowitz, J, Badescu, S, Palamarchuk, P, Filyk, V, Voloshchuk, A, Rud, V, Melnyk, E, Skrypnikov, A, Davidson, M, Saoud, J & Luthringer, R 2019, 'Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial', Schizophrenia Research, vol. 211, pp. 103-104. https://doi.org/10.1016/j.schres.2019.07.029

Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial. / Rabinowitz, Jonathan; Badescu, Stefan; Palamarchuk, Pavel et al.
In: Schizophrenia Research, Vol. 211, 09.2019, p. 103-104.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms

T2 - Results from an exploratory outcome of a randomized placebo-controlled trial

AU - Rabinowitz, Jonathan

AU - Badescu, Stefan

AU - Palamarchuk, Pavel

AU - Filyk, Viktor

AU - Voloshchuk, Anatolii

AU - Rud, Vadym

AU - Melnyk, Ellina

AU - Skrypnikov, Andrii

AU - Davidson, Michael

AU - Saoud, Jay

AU - Luthringer, Remy

N1 - Funding Information: The study phase 2b clinical trial was funded by Minerva Neurosciences.

PY - 2019/9

Y1 - 2019/9

UR - https://www.scopus.com/pages/publications/85071379553

U2 - 10.1016/j.schres.2019.07.029

DO - 10.1016/j.schres.2019.07.029

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 31375316

SN - 0920-9964

VL - 211

SP - 103

EP - 104

JO - Schizophrenia Research

JF - Schizophrenia Research

ER -

Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial

Bibliographical note

Funding

UN SDGs

Access to Document

Other files and links

Cite this